Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Medtronic's Implantable Holter ECG Recommended for Fast-Track Review
October 22, 2007
- CFS and Ain Pharmaciez to Merge in April 2008
October 22, 2007
- REGULATORY NEW IN BRIEF
October 22, 2007
- Nipro Licenses Double-Bag Kit Product to CWP in South Korea
October 22, 2007
- Main Price Survey to Target Transactions Made in September
October 22, 2007
- MEDRx Developing Products Using its Innovative DDS Technology
October 22, 2007
- Business Owners"Burden Is Lighter in Japan than in Other Countries: Mr Hara
October 22, 2007
- Sanofi-aventis Aims at 31 Submissions by the End of 2010
October 22, 2007
- DIA Workshop Focuses on Collaborative Clinical Trials in Asia
October 22, 2007
- R&D NEWS IN BRIEF
October 22, 2007
- SymBio Begins PI Study of SyB-0702 in US
October 22, 2007
- MediciNova Reports Positive PIIa Results for MN-221 for Status Asthmaticus
October 22, 2007
- PMDA Introduces New Training Program to Upgrade Its Reviewers
October 22, 2007
- FDA Accelerates Review of Generics to Promote Their Use
October 22, 2007
- Korosho to Require Overnight Delivery of Generics
October 22, 2007
- Teijin Aims at Share of Over 25% on Market for Osteoporosis Drugs
October 22, 2007
- Need to Promote Use of Generics Stressed at JPA Congress
October 22, 2007
- Eli Lilly Japan to Price Cialis \100 per Tablet Above Competitors"Prices
October 22, 2007
- Lupin of India Acquires Kyowa Pharm. Industry
October 22, 2007
- MEDICAL DEVICE NEWS IN BRIEF
October 15, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…